COVID-19 vaccines did not reduce the risk of severe COVID-19 among cancer patients who received radiation, CAR T-cell therapy, or HSCT.
All articles by Andrea S. Blevins Primeau, PhD, MBA
Researchers sought to determine whether patients with lymphoma receiving anticancer therapy had responses to COVID-19 vaccination.
Latest News Your top articles for WednesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses